Sridhar Natesan (S Natesan)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2014-2022
Publications (10 Years): 9

Top Topics

Parkinson Disease

Positron Emission Tomography

Top Venues

Molecular imaging

Translational psychiatry

The British journal of psychiatry : the journal of mental science

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Elise F Halff, Sridhar Natesan, David R Bonsall, Mattia Veronese, Anna Garcia-Hidalgo, Michelle Kokkinou, Sac-Pham Tang, Laura J Riggall, Roger N Gunn, Elaine E Irvine, Dominic J Withers, Lisa A Wells, Oliver D Howes
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity. Molecular imaging 2022 (2022)
Elise F Halff, Sridhar Natesan, David R Bonsall, Mattia Veronese, Anna Garcia-Hidalgo, Michelle Kokkinou, Sac-Pham Tang, Laura J Riggall, Roger N Gunn, Elaine E Irvine, Dominic J Withers, Lisa A Wells, Oliver D Howes
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity. Molecular imaging 2022 (2022)
Oliver D Howes, Thomas R E Barnes, Belinda R Lennox, Sarah Markham, Sridhar Natesan
Time to re-evaluate the risks and benefits of valproate and a call for action. The British journal of psychiatry : the journal of mental science 221 (6) (2022)
Elise F Halff, Sridhar Natesan, David R Bonsall, Mattia Veronese, Anna Garcia-Hidalgo, Michelle Kokkinou, Sac-Pham Tang, Laura J Riggall, Roger N Gunn, Elaine E Irvine, Dominic J Withers, Lisa A Wells, Oliver D Howes
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity. Molecular imaging 2022 (2022)
Elise F Halff, Sridhar Natesan, David R Bonsall, Mattia Veronese, Anna Garcia-Hidalgo, Michelle Kokkinou, Sac-Pham Tang, Laura J Riggall, Roger N Gunn, Elaine E Irvine, Dominic J Withers, Lisa A Wells, Oliver D Howes
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity. Molecular imaging 2022 (2022)
Elise F Halff, Sridhar Natesan, David R Bonsall, Mattia Veronese, Anna Garcia-Hidalgo, Michelle Kokkinou, Sac-Pham Tang, Laura J Riggall, Roger N Gunn, Elaine E Irvine, Dominic J Withers, Lisa A Wells, Oliver D Howes
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity. Molecular imaging 2022 (2022)
Ellis Chika Onwordi, Thomas Whitehurst, Ayla Mansur, Ben K Statton, Alaine Berry, Marina Quinlan, Declan P O'Regan, Maria Rogdaki, Tiago Reis Marques, Eugenii A Rabiner, Roger N Gunn, Anthony Christopher Vernon, Sridhar Natesan, Oliver D Howes
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study. Translational psychiatry 11 (1) (2021)
Ellis Chika Onwordi, Elise F Halff, Thomas Whitehurst, Ayla Mansur, Marie-Caroline Cotel, Lisa Wells, Hannah Creeney, David Bonsall, Maria Rogdaki, Ekaterina Shatalina, Tiago Reis Marques, Eugenii A Rabiner, Roger N Gunn, Sridhar Natesan, Anthony Christopher Vernon, Oliver D Howes
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats. Nature communications 11 (1) (2020)
Michelle Kokkinou, Elaine E Irvine, David R Bonsall, Sridhar Natesan, Lisa A Wells, Mark Smith, Justyna Glegola, Eleanor J Paul, Kyoko Tossell, Mattia Veronese, Sanjay Khadayate, Nina Dedic, Seth C Hopkins, Mark A Ungless, Dominic J Withers, Oliver D Howes
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine. Molecular psychiatry 26 (6) (2020)
Sridhar Natesan, S Ashworth, J Nielsen, S-P Tang, C Salinas, S Kealey, J B Lauridsen, T B Stensbøl, R N Gunn, E A Rabiner, S Kapur
Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation. Translational psychiatry 4 (2014)